Publication | Closed Access

Glial expression of cannabinoid CB2 receptors and fatty acid amide hydrolase are beta amyloid–linked events in Down’s syndrome

Down SyndromeCannabinoid Cb2 ReceptorsNeurodegenerative DiseasesCannabis UseMolecular NeuroscienceAlzheimer's DiseasePsychiatryNeuropharmacologyGlial ExpressionNeurologyNeuroscienceBrain PathologyMedicineCannabinoid PharmacologyFatty AcidSocial Sciences